Skin Scarring
9
1
3
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
11%
1 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
Device for Improving Skin Quality and Texture on the Face and Neck
Skin Elasticity Measurements of the Face and Surgical Scars Stratified by Age and Skin Type
Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment
Use of Botulinum Toxin A in Direct Eyebrow Lift Scar
Negative Pressure Wound Therapy Compared to Traditional Care After Skin Grafting
Tazarotene 0.045% Lotion for Treating PIE and PIH in Subjects With Acne
Restenosis in Coronary Stents And Cutaneous HEaLing
Light Emitting Diode-Red Light (LED-RL) Phototherapy for Skin Scarring Prevention
Early Carbon Dioxide Laser Therapy for Alleviation of Incisional Scar Burden